Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study

Background. Recurrent spontaneous urticaria (RSU) is rare in children, thus, it is debilitating condition that always requires treatment. There are several limitations on the drugs use in children with RSU. Omalizumab is the effective medication for achieving the control of RSU, used in adolescents...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Vera G. Kalugina (Tekijä), Elena A. Vishneva (Tekijä), Leyla S. Namazova-Baranova (Tekijä)
Aineistotyyppi: Kirja
Julkaistu: Union of pediatricians of Russia, 2020-08-01T00:00:00Z.
Aiheet:
Linkit:Connect to this object online.
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Internet

Connect to this object online.

3rd Floor Main Library

Saatavuus: 3rd Floor Main Library
Hyllypaikka: A1234.567
Nide 1 Saatavissa